Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Dyslipidemia

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 6 articles: HTML format Text format

Single Articles

September 2018
1. PRADHAN AD, Paynter NP, Everett BM, Glynn RJ, et al
   Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
   Am Heart J. 2018;206:80-93.
   PubMed     Text format     Abstract available
   
   
   July 2018
2. PAGIDIPATI NJ, Hellkamp AS, Sharma PP, Wang TY, et al
   High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States.
   Am Heart J. 2018;204:151-155.
   PubMed     Text format     Abstract available
   
   
   March 2018
3. TAYLOR BA, Dager AD, Panza GA, Zaleski AL, et al
   The effect of high-dose atorvastatin on neural activity and cognitive function.
   Am Heart J. 2018;197:166-174.
   PubMed     Text format     Abstract available
   
   
   March 2017
4. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
   Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
   Am Heart J. 2017;185:74-84.
   PubMed     Text format     Abstract available
   
   
   November 2016
5. RERUP SA, Bang LE, Mogensen UM, Engstrom T, et al
   The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
   Am Heart J. 2016;181:35-42.
   PubMed     Text format     Abstract available
   
   
   August 2016
6. RIDKER PM, Amarenco P, Brunell R, Glynn RJ, et al
   Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Eve
   Am Heart J. 2016;178:135-44.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: